AC
ACLARION
ACON·NASDAQBroomfield COFounded 201520 employees
Micro CapbiotechPublicMusculoskeletal
Platform: Nociscan AI
Market Cap
$0.01B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ACON)
Loading ACON stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ACO-697 | ACO-697 | Phase 1/2 | 1 | TIM-3 | Hemophilia AWilms | ||
| Polalemzoparlimab | ACO-6239 | Phase 3 | 3 | SMN2 | Prostate CaWM |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)